Saturday, March 15, 2025 | 11:59 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Bafna Pharmaceuticals announces upgradation of credit ratings

Image

Capital Market

From CRISIL

Bafna Pharmaceuticals announced that CRISIL has upgraded the rating as CRISIL BB-/stable (Upgraded from CRISIL D) for Long Term rating & CRISIL A4+ (Upgraded from CRISIL D) for Short term Rating in respect of Total bank facilities.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 19 2014 | 3:02 PM IST

Explore News